Adding Bismuth to Rabeprazole-based First-line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori

NCT03108287 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

162

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: RAK therapy
DRUG: RBAK therapy

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital